In vivo glutathione levels in young persons with bipolar disorder: A magnetic resonance spectroscopy study

Journal of Psychiatric Research

Volumn 47, Issue 3, 2013, Pages 412-417

  Lagopoulos, J ^a   Hermens, D F ^a   Tobias Webb, J ^a   Duffy, S ^a   Naismith, S L ^a   White, D ^a   Scott, E ^a   Hickie, I B ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Bipolar disorder; Glutathione; N acetyl cysteine; Spectroscopy

Indexed keywords

GLUTATHIONE;

ADOLESCENT; ADULT; ANTERIOR CINGULATE; ARTICLE; BIPOLAR DISORDER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 84873524925     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.12.006     Document Type: Article

References (39)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, (4th ed. text revision. ed.), American Psychiatric Association., Washington DC.
2. Andreazza A.C., Kauer-Sant'anna M., Frey B.N., Bond D.J., Kapczinski F., Young L.T., et al. Oxidative stress markers in bipolar disorder: a meta-analysis. Journal of Affective Disorders 2008, 111:135-144.
3. Andrews G., Slade T. Interpreting scores on the Kessler Psychological Distress Scale (K10). Australian & New Zealand Journal of Public Health 2001, 25:494-497.
4. Angst J. The bipolar spectrum. British Journal of Psychiatry 2007, 190:189-191.
5. Berk M., Dean O., Cotton S.M., Gama C.S., Kapczinski F., Fernandes B.S., et al. The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial. Journal of Affective Disorders 2011, 135:389-394.
6. Blumberg H.P., Martin A., Kaufman J., Leung H.C., Skudlarski P., Lacadie C., et al. Frontostriatal abnormalities in adolescents with bipolar disorder: preliminary observations from functional MRI. American Journal of Psychiatry 2003, 160:1345-1347.
7. Caligiuri M.P., Brown G.G., Meloy M.J., Eyler L.T., Kindermann S.S., Eberson S., et al. A functional magnetic resonance imaging study of cortical asymmetry in bipolar disorder. Bipolar Disorders 2004, 6:183-196.
8. Chang K., Adleman N.E., Dienes K., Simeonova D.I., Menon V., Reiss A. Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: a functional magnetic resonance imaging investigation. Archives of General Psychiatry 2004, 61:781-792.
9. Dean O.M., van den Buuse M., Bush A.I., Copolov D.L., Ng F., Dodd S., et al. A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice. Current Medicinal Chemistry 2009, 16:2965-2976.
10. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997, 386:824-827.
11. Dringen R. Glutathione metabolism and oxidative stress in neurodegeneration. European Journal of Biochemistry 2000, 267:4903.
12. Dringen R. Metabolism and functions of glutathione in brain. Progress in Neurobiology 2000, 62:649-671.
13. Fullerton J.M., Tiwari Y., Agahi G., Heath A., Berk M., Mitchell P.B., et al. Assessing oxidative pathway genes as risk factors for bipolar disorder. Bipolar Disorders 2010, 12:550-556.
14. Goldman H.H., Skodol A.E., Lave T.R. Revising axis V for DSM-IV: a review of measures of social functioning. American Journal of Psychiatry 1992, 149:1148-1156.
15. Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social & Clinical Psychology 1967, 6:278-296.
16. Kessler R.C., Andrews G., Colpe L.J., Hiripi E., Mroczek D.K., Normand S.L., et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychological Medicine 2002, 32:959-976.
17. Kupfer D.J. The increasing medical burden in bipolar disorder. Journal of the American Medical Association 2005, 293:2528-2530.
18. Lagopoulos J., Ivanovski B., Malhi G.S. An event-related functional MRI study of working memory in euthymic bipolar disorder. Journal of Psychiatry and Neuroscience 2007, 32:174-184.
19. Magalhaes P.V., Dean O.M., Bush A.I., Copolov D.L., Malhi G.S., Kohlmann K., et al. N-acetylcysteine for major depressive episodes in bipolar disorder. Revista Brasileira de Psiquiatria 2011, 33:374-378.
20. Malhi G.S., Lagopoulos J., Ward P.B., Kumari V., Mitchell P.B., Parker G.B., et al. Cognitive generation of affect in bipolar depression: an fMRI study. European Journal of Neuroscience 2004, 19:741-754.
21. Martinez-Aran A., Vieta E., Colom F., Torrent C., Sanchez-Moreno J., Reinares M., et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disorders 2004, 6:224-232.
22. Merikangas K.R., Kalaydjian A. Magnitude and impact of comorbidity of mental disorders from epidemiologic surveys. Current Opinion in Psychiatry 2007, 20:353-358.
23. Merikangas K.R., Jin R., He J.P., Kessler R.C., Lee S., Sampson N.A., et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Archives of General Psychiatry 2011, 68:241-251.
24. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychological Reports 1962, 10:799-812.
25. Phillips M.L. The neural basis of mood dysregulation in bipolar disorder. Cognitive Neuropsychiatry 2006, 11:233-249.
26. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine 1993, 30:672-679.
27. Robinson L.J., Ferrier I.N. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disorders 2006, 8:103-116.
28. Sanchez-Moreno J., Martinez-Aran A., Colom F., Scott J., Tabares-Seisdedos R., Sugranyes G., et al. Neurocognitive dysfunctions in euthymic bipolar patients with and without prior history of alcohol use. Journal of Clinical Psychiatry 2009, 70:1120-1127.
29. Sax K.W., Strakowski S.M., Zimmerman M.E., DelBello M.P., Keck P.E., Hawkins J.M. Frontosubcortical neuroanatomy and the continuous performance test in mania. American Journal of Psychiatry 1999, 156:139-141.
30. Scott E., Naismith S.L., Whitwell B.G., Hamilton B., Chudleigh C., Hickie I.B. Delivering youth-specific mental health services: the advantages of a collaborative, multi-disciplinary system. Australasian Psychiatry 2009, 17:189-194.
31. Scott E.M., Hermens D.F., Glozier N., Naismith S.L., Guastella A.J., Hickie I.B. Targeted primary care-based mental health services for young Australians. Medical Journal of Australia 2012, 196:136-140.
32. Talairach J., Tournoux P. Co-planar stereotaxic atlas of the human brain: 3-Dimensional proportional system: An approach to cerebral imaging 1987, Thieme, New York.
33. Wang J.F., Shao L., Sun X., Young L.T. Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disorders 2009, 11:523-529.
34. Wechsler D. Wechsler test of adult reading 2002, Psychological Corporation, San Antonio, TX.
35. Wood S.J., Berger G.E., Wellard R.M., Proffitt T.M., McConchie M., Berk M., et al. Medial temporal lobe glutathione concentration in first episode psychosis: a 1H-MRS investigation. Neurobiology of Disease 2009, 33:354-357.
36. Yao J.K., Leonard S., Reddy R. Altered glutathione redox state in schizophrenia. Disease Markers 2006, 22:83-93.
37. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry 1978, 133:429-435.
38. Yurgelun-Todd D.A., Waternaux C.M., Cohen B.M., Gruber S.A., English C.D., Renshaw P.F. Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. American Journal of Psychiatry 1996, 153:200-205.
39. Zhang Y., Brady M., Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Transactions on Medical Imaging 2001, 20:45-57.